Hello, welcome to the special meeting of stockholders of Aura Biosciences, Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the virtual shareholder meeting portal. Good morning, everyone. My name is Natalie Holles, Chief Executive Officer and President of Aura Biosciences, Inc. This meeting is now called to order. I've asked Ryan Mitteness of our outside legal counsel, Fenwick, to record the minutes. It's a pleasure to welcome our shareholders to the special meeting of stockholders of Aura Biosciences, Inc., being held today, Wednesday, August 5th, 2026. Today's meeting is being held in accordance with the corporation's amended and restated bylaws and Delaware law and is being held virtually. We have stockholders attending via the web portal we provided. Our meeting today will consist of the formal business described in our notice and proxy statement, a copy of which was mailed on or about June 29th, 2026, to all our stockholders of record at the close of business on June 12th, 2026. Before proceeding to the formal business, I would like to recognize Amy Elazzouzi, Aura Biosciences' Senior Vice President of Finance and Principal Accounting Officer, and Conor Kilroy, Aura Biosciences' Chief Legal Officer and Secretary, who are with us today. Let's proceed to the formal business of the meeting, notice of which was sent to all shareholders of record as of the close of business on June 12th, 2026. Shareholders of record on that date are entitled to vote at this meeting. Our record of stockholders as of that date has been on file at the principal place of business of the corporation for the last 10 days immediately prior to the date of this meeting and has been available for inspection by any stockholder during that period at any time during normal business hours. Rules of conduct for the meeting are available in the meeting materials section. Please note that only stockholders who have logged in using their 16-digit control number will be able to vote and ask questions at the meeting. If you have any questions, I will encourage you to please submit them now so that they will be queued to be answered. If any stockholder wishes to address management during the formal part of this meeting, please do so by submitting your question in writing through the virtual meeting platform via the link provided. The board of directors have appointed Ms. Jenna Bentley to act as Inspector of Election for this special meeting. She will tabulate the results of the voting. The Inspector of Election has signed the oath of her office, which will be filed with the minutes of this meeting. Ms. Bentley, do we have a quorum present? Ms. President, of the 103,436,416 shares of common stock entitled to vote at the meeting, at least 89,490,726 shares are represented either in person or by proxy, and therefore a quorum is present. I declare that a quorum is present. We may now proceed to transact the business for which this meeting has been called. Let me briefly describe the voting procedures. If you have previously turned in your proxy in a timely manner and you do not intend to change your vote, it is not necessary that you complete another proxy or ballot. Your vote will be counted. If you are eligible to vote and have not submitted your proxy, or if you want to change your vote, you may do so by clicking on the Vote Here button in the virtual meeting platform. In order to allow stockholders to vote through the virtual meeting platform at any time during this meeting, I now declare the polls open for voting. It is now 9:34 A.M. on August 5th, 2026. Our first item of business is to approve an amendment to Aura Biosciences' Tenth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150 million - 500 million. The board of directors unanimously recommends that stockholders vote in favor of this proposal. Have we received any questions concerning the proposal? There have been no questions concerning the proposal. The second item of business is to approve amendment number 1 to Aura Biosciences 2021 Stock Option and Incentive Plan. Board of Directors unanimously recommends that stockholders vote in favor of this proposal. Have we received any questions concerning the proposal? There have been no questions concerning the proposal. Anyone who has not yet voted and desires to do so, please do so now through the virtual meeting platform. It is now 9:35 A.M. on August 5th, 2026, and the polls for each matter to be voted on at this meeting are now closed. No additional ballots, proxies, or votes and no changes or revocations will be accepted. Inspector of Election, please report on the results of this voting. With regard to proposal one, the votes cast for exceed the votes cast against the proposal, approving the amendment to Aura Biosciences Tenth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150 million - 500 million. With regard to proposal two, a majority of the votes properly cast for and against have voted for the proposal approving amendment number one to Aura Biosciences 2021 Stock Option and Incentive Plan. Thank you, Ms. Bentley. I declare that all of the proposals presented at the meeting have been approved by the stockholders. The final results of voting, including any ballots and proxies recorded during this meeting, will be set forth in the report of the Inspector of Election and will be included in the minutes of this meeting. The final results will also be included in our reports filed with the SEC. There being no other matters for consideration at this meeting, I hereby adjourn the meeting. This now concludes the meeting. Thank you for joining, and have a pleasant day.